◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Towa Pharmaceutical Co., Ltd. (4553)

Name: Towa Pharmaceutical Co., Ltd.（4553）— 财务报表历史
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

来自官方财务报表的收入、利润与现金流历史。

Healthcare · 华尔街（美国） · 最近更新： 2026-10-02

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs.

关键数据

市值: JPY 172 billion
收入（截至 2026-03-31 财年）: JPY 273.7B
净利润: JPY 5.2B
毛利率: 36.2%
净利率: 1.9%

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表	2026-03-31	2025-03-31	2024-03-31	2023-03-31
总收入	JPY 273.7B	JPY 259.6B	JPY 227.9B	JPY 208.9B
毛利	JPY 99.1B	JPY 94.7B	JPY 81.4B	JPY 72.7B
营业利润（EBIT）	JPY 23.1B	JPY 23.2B	JPY 17.6B	JPY 5.5B
净利	JPY 5.2B	JPY 19.0B	JPY 16.2B	JPY 2.2B

来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 4553 交互式查看器。 /companies/us/4553

类似公司

4887 · Sawai Group Holdings Co., Ltd.

本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.